Pertussis in the Netherlands;Kinkhoest in Nederland

Nederlands Tijdschrift voor Geneeskunde

Volumn 154, Issue 7, 2010, Pages 315-320

  De Greeff, Sabine C ^a   De Melker, Hester E ^a   Mooi, Frits R ^b  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b Laboratorium Voor Infectieziekten en Screening   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PERTUSSIS VACCINE;

BORDETELLA PERTUSSIS; HUMAN; NETHERLANDS; NONHUMAN; PATHOGENESIS; PERTUSSIS; REVIEW; VACCINATION;

EID: 77749307709     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Ratulangie CJ. De sterfte aan kinkhoest en de betekenis van de vaccinatie hiertegen. Ned Tijdschr Geneeskd. 1957;101:1801-6.
2. Roush SW, Murphy TV. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. JAMA. 2007;298:2155-63.
3. de Greeff S, Mooi F, Westerhof A, Verbakel J, Peeters M, Heuvelman C, et al. Pertussis disease burden within the household: how to protect young infants. Clin Infect Dis. [ter perse]
4. van Lier EA, Oomen PJ, Oostenbrug MW, Zwakhals SL, Drijfhout IH, de Hoogh PA, et al. Hoge vaccinatiegraad van het Rijksvaccinatieprogramma in Nederland. Ned Tijdschr Geneeskd. 2009;153:950-7.
5. de Melker HE, Schellekens JF, Neppelenbroek SE, Mooi FR, Rumke HC, Conyn-van Spaendonck MA. Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data. Emerg Infect Dis. 2000;6:348-57.
6. de Greeff SC, Mooi FR, Schellekens JF, de Melker HE. Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in The Netherlands. Pediatr Infect Dis J. 2008;27:218-23.
7. Mooi FR. Bordetella pertussis and vaccination: The persistence of a genetically monomorphic pathogen. Infect Genet Evol. [ter perse]
8. Wendelboe AM, Van Rie A, Salmaso S, Englund JA. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J. 2005;24:S58-61.
9. King AJ, Berbers G, van Oirschot HF, Hoogerhout P, Knipping K, Mooi FR. Role of the polymorphic region 1 of the Bordetella pertussis protein pertactin in immunity. Microbiology. 2001;147:2885-95.
10. Mooi F, Van Loo I, Van Gent M, He Q, Bart M, Heuvelman K, et al. Bordetella pertussis strains with increased toxin production associated with pertussis resurgence. Emerging Infectious Diseases. 2009;15:1206-13.
11. Paddock CD, Sanden GN, Cherry JD, Gal AA, Langston C, Tatti KM, et al. Pathology and pathogenesis of fatal Bordetella pertussis infection in infants. Clin Infect Dis. 2008;47:328-38.
12. Bouchez V, Brun D, Cantinelli T, Dore G, Njamkepo E, Guiso N. First report and detailed characterization of B. pertussis isolates not expressing Pertussis Toxin or Pertactin. Vaccine. 2009;27:6034-41.
13. de Melker HE, Versteegh FG, Schellekens JF, Teunis PF, Kretzschmar M. The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys. J Infect. 2006;53:106-13.
14. de Greeff SC, Westerhof A. Kinkhoest op een roze wolk: de BINKI-studie. Infectieziekten Bulletin. 2008;2:57-8.
15. von Konig CH. Use of antibiotics in the prevention and treatment of pertussis. Pediatr Infect Dis J. 2005;24:S66-8.
16. Nederlands Huisartsen Genootschap. NHG-Standaard 'Acuut hoesten.' Huisarts en Wetenschap. 2003;9:496-506. (http://nhg.artsennet.nl/kenniscentrum/ k-richtlijnen/k-nhgstandaarden/SamenvattingskaartjeNHGStandaard/M78-svk.htm)
17. Landelijke Coördinatie Infectieziektebestrijding. Protocol Pertussis (infectieziektebestrijding). http://www.rivm.nl/cib/infectieziekten-A-Z/ infectieziekten/Pertussis/.
18. Niessen WJ, Broer J, Schellekens JF. Meldingsplicht voor kinkhoest niet effectief om ongevaccineerde kinderen te beschermen. Ned Tijdschr Geneeskd. 2008;152:86-90.
19. De Serres G, Shadmani R, Duval B, Boulianne N, Dery P, Douville Fradet M, et al. Morbidity of pertussis in adolescents and adults. J Infect Dis. 2000;182:174-9.
20. van der Zee A, Agterberg C, Peeters M, Mooi F, Schellekens J. A clinical validation of Bordetella pertussis and Bordetella parapertussis polymerase chain reaction: comparison with culture and serology using samples from patients with suspected whooping cough from a highly immunized population. J Infect Dis. 1996;174:89-96.
21. de Melker HE, Versteegh FG, Conyn-Van Spaendonck MA, Elvers LH, Berbers GA, van Der Zee A, et al. Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis. J Clin Microbiol. 2000;38:800-6.
22. Chatterjee A, Plummer S, Heybrock B, Bardon T, Eischen K, Hall M, et al. A modified "cover your cough" campaign prevents exposures of employees to pertussis at a children's hospital. Am J Infect Control. 2007;35:489-91.
23. Bettinger JA, Halperin SA, De Serres G, Scheifele DW, Tam T. The effect of changing from whole-cell to acellular pertussis vaccine on the epidemiology of hospitalized children with pertussis in Canada. Pediatr Infect Dis J. 2007;26:31-5.
24. Zwart B, van Veenendaal M, Vandenbroucke-Grauls C, Kok J, Visser C. Kinkhoestuitbraak op een neonatologieafdeling. Infectieziekten bulletin. 2007;18:90-1.
25. Mooi FR, de Greeff SC. The case for maternal vaccination against pertussis. Lancet Infect Dis. 2007; 7:614-24.
26. Murphy TV, Slade BA, Broder KR, Kretsinger K, Tiwari T, Joyce PM, et al. Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2008;57:1-51.
27. Knuf M, Schmitt HJ, Wolter J, Schuerman L, Jacquet JM, Kieninger D, et al. Neonatal vaccination with an acellular pertussis vaccine accelerates the acquisition of pertussis antibodies in infants. J Pediatr. 2008;152:655-60.
28. Shinall MC, Jr., Peters TR, Zhu Y, Chen Q, Poehling KA. Potential impact of acceleration of the pertussis vaccine primary series for infants. Pediatrics. 2008;122:1021-6.
29. Siegrist CA. Blame vaccine interference, not neonatal immunization, for suboptimal responses after neonatal diphtheria, tetanus, and acellular pertussis immunization. J Pediatr. 2008;153:305-7.